US
First Trust Nasdaq Pharmaceuticals ETF
FTXH · Equity
$34.32
+1.18%
Assets
n/a
Expense ratio
0.60%
Holdings
51
1Y return
+40.4%
Forward P/E
n/a
Top 10 holdings
+53.1%
Return and risk
| 1Y total return | +40.4% |
| 3Y total return | +33.7% |
| 5Y total return | +42.2% |
| 3Y CAGR | +10.2% |
| 5Y CAGR | +7.3% |
| Beta | 0.47 |
| RSI | 48.6 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 51 |
| Expense ratio | 0.60% |
| Dividend yield | +1.2% |
| Top 10 holdings | +53.1% |
| Volume | 6.2K |
All ETF indicators
| All Time High | 35.61 |
| All Time High Change | -4.72 |
| All Time High Date | 2026-02-27 |
| All Time Low | 16.28 |
| All Time Low Change | 108.42 |
| All Time Low Date | 2020-03-23 |
| Atr | 0.38 |
| Beta | 0.47 |
| Cagr1y | 40.41 |
| Cagr3y | 10.16 |
| Cagr5y | 7.3 |
| Ch1m | -0.29 |
| Ch1w | -0.11 |
| Ch1y | 38.38 |
| Ch3m | -2.81 |
| Ch3y | 27.65 |
| Ch5y | 32.7 |
| Ch6m | 8.37 |
| Ch YTD | 3.01 |
| Close | 33.92 |
| Div CAGR3 | 5.88 |
| Div CAGR5 | 12.8 |
| Dividend Growth | -12.21 |
| Dividend Growth Years | 6 |
| Dividend Years | 11 |
| Dividend Yield | 1.23 |
| Dps | 0.42 |
| Ex Div Date | 2026-03-26 |
| High52 | 35.61 |
| High52ch | -3.62 |
| High52 Date | 2026-02-27 |
| Inception Date | 2016-09-20 |
| Isin | US33738R8372 |
| Last Dividend | 0.06 |
| Low52 | 24.25 |
| Low52ch | 41.54 |
| Low52 Date | 2025-05-14 |
| Ma150 | 32.99 |
| Ma150ch | 2.84 |
| Ma20 | 34.03 |
| Ma200 | 31.66 |
| Ma200ch | 7.17 |
| Ma20ch | -0.31 |
| Ma50 | 34.02 |
| Ma50ch | -0.25 |
| Payment Date | 2026-03-31 |
| Payout Frequency | Quarterly |
| Payout Ratio | 23.06 |
| Price Date | 2026-05-12 |
| Rsi | 48.6 |
| Rsi Monthly | 66.36 |
| Rsi Weekly | 56.61 |
| Sharpe Ratio | 1.79 |
| Sortino Ratio | 3.35 |
| Top10holdings | 53.09 |
| Tr1m | -0.29 |
| Tr1y | 40.38 |
| Tr3m | -2.64 |
| Tr3y | 33.68 |
| Tr5y | 42.22 |
| Tr6m | 8.99 |
| Tr YTD | 3.18 |